Danimer Scientific, Inc. (NYSE:DNMR) Q4 2022 Earnings Conference Call March 28, 2023 5:00 PM ET

Company Participants

James Palczynski - Investor Relations

Steve Croskrey - Chairman and Chief Executive Officer

Mike Hajost - Chief Financial Officer

Conference Call Participants

Jon Tanwanteng - CJS Securities

Kevin Estok - Jefferies

Operator

Greetings and welcome to the Danimer Scientific 2022 Fourth Quarter and Full Year Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the presentation over to Mr. James Palczynski, the company’s Investor Relations representative.

James Palczynski

Thank you, operator. Good afternoon, everyone and thank you for joining us today for Danimer Scientific’s 2022 fourth quarter and full year earnings call. Leading the call today is Steve Croskrey, Chairman and Chief Executive Officer; and Mike Hajost, Danimer’s Chief Financial Officer.

I’d like to note that there is a slide deck that accompanies today’s discussion, which is available on the Investor Relations section of our website at danimerscientific.com. I’ll call your attention to the company’s safe harbor language which is published in our SEC filings and also on Slide 2 of the presentation I just referenced.

On today’s call, we may discuss forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 as amended. Forward-looking statements include, among other things, statements regarding future results of operations, including margins, profitability, capacity, production, customer programs and market demand levels. Actual results could differ materially from what is expressed or implied in our forward-looking statements. The company assumes no obligation to update any forward-looking statements to reflect events or circumstances after the date hereof, except as required by law.

Today’s presentation also includes references to non-GAAP financial measures within the meaning of SEC Regulation G. We believe these non-GAAP measures have analytical value, but note that they should be taken as an additional measure of performance to GAAP results. We have provided reconciliations for non-GAAP financial measures to the most comparable GAAP financial measures in our earnings release and our presentation.

Thank you. And it’s now my pleasure to turn the call over to Steve Croskrey, Chairman and Chief Executive Officer of Danimer Scientific.

Steve Croskrey

Thank you, James. Good afternoon to everyone and thank you for joining us. As you know, we pre-released preliminary fourth quarter and full year results for 2022 on March 20 when we announced the successful completion of our new $130 million senior term loan.